References
- You JS , JonesPA . Cancer genetics and epigenetics: two sides of the same coin?Cancer Cell22 , 9 – 20 ( 2012 ).
- Kanai Y , UshijimaS , NakanishiY , SakamotoM , HirohashiS . Mutation of the DNA methyltransferase (DNMT) 1 gene in human colorectal cancers . Cancer Lett . 192 , 75 – 82 ( 2003 ).
- Tahara T , YamamotoE , MadireddiPet al. Colorectal carcinomas with CpG island methylator phenotype 1 frequently contain mutations in chromatin regulators . Gastroenterology doi:https://doi.org/10.1053/j.gastro.2013.10.060 ( 2013 ) ( Epub ahead of print ).
- Crea F , PaolicchiE , MarquezVE , DanesiR . Polycomb genes and cancer: time for clinical application?Crit. Rev. Oncol. Hematol.83 , 184 – 193 ( 2012 ).
- Banck MS , KanwarR , KulkarniAAet al. The genomic landscape of small intestine neuroendocrine tumors . J. Clin. Invest.123 , 2502 – 2508 ( 2013 ).
- Park JH , LeeJY , ShinDH , JangKS , KimHJ , KongG . Loss of Mel-18 induces tumor angiogenesis through enhancing the activity and expression of HIF-1α mediated by the PTEN/PI3K/Akt pathway . Oncogene30 , 4578 – 4589 ( 2011 ).
- Wang W , YuasaT , TsuchiyaNet al. The novel tumor-suppressor Mel-18 in prostate cancer: its functional polymorphism, expression and clinical significance . Int. J. Cancer125 , 2836 – 2843 ( 2009 ).
- Matsuo F , YanoK , SaitoHet al. Mutation analysis of the mel-18 gene that shows decreased expression in human breast cancer cell lines . Breast Cancer9 , 33 – 38 ( 2002 ).
- Riis ML , LüdersT , NesbakkenAJ , VollanHS , KristensenV , BukholmIR . Expression of BMI-1 and Mel-18 in breast tissue - a diagnostic marker in patients with breast cancer . BMC Cancer10 , 686 ( 2010 ).
- Yu YL , SuKJ , HsiehYHet al. Effects of EZH2 polymorphisms on susceptibility to and pathological development of hepatocellular carcinoma . PLoS ONE8 , e74870 ( 2013 ).
- Zhou Y , DuWD , WuQet al. EZH2 genetic variants affect risk of gastric cancer in the Chinese Han population . Mol. Carcinog. doi:10.1002/mc.21871 ( 2012 ) ( Epub ahead of print ).
- Yoon KA , GilHJ , HanJ , ParkJ , LeeJS . Genetic polymorphisms in the polycomb group gene EZH2 and the risk of lung cancer . J. Thorac. Oncol.5 , 10 – 16 ( 2010 ).
- Crea F , FornaroL , PaolicchiEet al. An EZH2 polymorphism is associated with clinical outcome in metastatic colorectal cancer patients . Ann. Oncol.23 , 1207 – 1213 ( 2012 ).
- Paolicchi E , PacettiP , GiovannettiEet al. A single nucleotide polymorphism in EZH2 predicts overall survival rate in patients with cholangiocarcinoma . Oncol. Lett.6 , 1487 – 1491 ( 2013 ).
- Wang W , YuasaT , TsuchiyaNet al. The novel tumor-suppressor Mel-18 in prostate cancer: its functional polymorphism, expression and clinical significance . Int. J. Cancer125 , 2836 – 2843 ( 2009 ).
- Magitta NF , B⊘eWolff AS , JohanssonSet al. A coding polymorphism in NALP1 confers risk for autoimmune Addison’s disease and type 1 diabetes . Genes Immun.10 ( 2 ), 120 – 124 ( 2009 ).
- Saramäki OR , TammelaTL , MartikainenPM , VessellaRL , VisakorpiT . The gene for polycomb group protein enhancer of zeste homolog 2 (EZH2) is amplified in late-stage prostate cancer . Genes Chromosomes Cancer45 , 639 – 645 ( 2006 ).
- Häyry V , TannerM , BlomTet al. Copy number alterations of the polycomb gene BMI1 in gliomas . Acta Neuropathol.116 , 97 – 102 ( 2008 ).
- Pedeutour F , MaireG , PierronAet al. A newly characterized human well-differentiated liposarcoma cell line contains amplifications of the 12q12-21 and 10p11-14 regions . Virchows Arch.461 , 67 – 78 ( 2012 ).
- Crea F , SunL , PikorL , FrumentoP , LamWL , HelgasonCD . Mutational analysis of Polycomb genes in solid tumours identifies PHC3 amplification as a possible cancer-driving genetic alteration . Br. J. Cancer109 , 1699 – 1702 ( 2013 ).
- McCabe MT , OttHM , GanjiGet al. EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations . Nature492 , 108 – 112 ( 2012 ).
- Berger ML , EckS , RubergSJ . Raising the bar of efficacy for drug approval requires an understanding of patient diversity . J. Clin. Oncol.28 , e343 – e344 ( 2010 ).